Proximus SA (formerly Belgacom SA):企業のM&A・事業提携・投資動向

◆英語タイトル:Proximus SA (formerly Belgacom SA) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2373
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Proximus SA (formerly Belgacom SA) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Proximus SA (formerly Belgacom SA) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Proximus SA (formerly Belgacom SA) since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Proximus SA (formerly Belgacom SA)’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Proximus SA (formerly Belgacom SA). These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Proximus SA (formerly Belgacom SA)’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Proximus SA (formerly Belgacom SA) and its subsidiaries since 2007.
- Information about key financial and legal advisors for Proximus SA (formerly Belgacom SA)’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Proximus SA (formerly Belgacom SA)’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 4
LIST OF TABLES 5
LIST OF FIGURES 5
MERGERS & ACQUISITIONS 6
Mergers and Acquisitions – Deal reports 6
CORPORATE VENTURING 26
Corporate Venturing – Deal reports 26
PARTNERSHIP 30
Partnership – Deal reports 30
DIVESTMENTS 33
Divestments – Overview 33
Divestments – Deal reports 34
PRIVATE EQUITY & OWNERSHIP 53
Private Equity and Ownership – Deal reports 53
APPENDIX 55
Contact Us 55
About MarketLine Financial Deals Database 55
Deal Definition and Methodology 57
About MarketLine 64

List of Tables
Table 1: Proximus SA divestments volume and value trend (2014-YTD2018)
Table 2: Proximus SA divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: Proximus SA divestments volume and value trend (2014-YTD2018)
Figure 2: Proximus SA divestments by geography (2014-YTD2018)

★海外企業調査レポート[Proximus SA (formerly Belgacom SA):企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Queen’s University Belfast:製薬・医療:M&Aディール及び事業提携情報
    Summary Queen's University Belfast (Queen’s University) is an educational institution that offers education and research services. The institute provides undergraduate, professional development and postgraduate programs. Its postgraduate programs comprise postgraduate diploma in nursing, MSc advance …
  • TETRA Technologies Inc (TTI):企業の財務・戦略的SWOT分析
    Summary TETRA Technologies Inc (TETRA) is an oil and gas company that offers completion fluids and associated products and services. The company’s services comprise compression services, fluid, filtration and tools services, offshore services, production testing, rig cooling services, technology cen …
  • Ubisoft Entertainment S.A.:企業の戦略・SWOT・財務情報
    Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report Summary Ubisoft Entertainment S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Ferrellgas Partners, L.P.:企業の戦略・SWOT・財務情報
    Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Ferrellgas Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Micron Technology Inc:企業のM&A・事業提携・投資動向
    Micron Technology Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Micron Technology Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Noramco Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Noramco Inc (Noramco), a subsidiary of Johnson & Johnson is a manufacturer and distributor of bulk active ingredients. The company's products comprise amphetamine L aspartate, amphetamine sulfate, dextroamphetamine saccharate, dextroamphetamine sulfate, buprenorphine base, buprenorphine HCL, …
  • Hyduke Energy Services Inc:企業の戦略的SWOT分析
    Hyduke Energy Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • 23andMe Inc-製薬・医療分野:企業M&A・提携分析
    Summary 23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization …
  • China Petroleum & Chemical Corp (600028):石油・ガス:M&Aディール及び事業提携情報
    Summary China Petroleum & Chemical Corp (Sinopec Corp), a subsidiary of China Petrochemical Corporation, is a vertically integrated energy and chemical company. It is involved in the oil and gas exploration and production, extraction, pipeline transmission and marketing; oil refining; and production …
  • Genting Malaysia Berhad:企業の戦略・SWOT・財務情報
    Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report Summary Genting Malaysia Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Natural Beauty Bio-Technology Ltd.:戦略・SWOT・企業財務分析
    Natural Beauty Bio-Technology Ltd. - Strategy, SWOT and Corporate Finance Report Summary Natural Beauty Bio-Technology Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Attijariwafa Bank SA (ATW):企業の財務・戦略的SWOT分析
    Attijariwafa Bank SA (ATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SINTX Technologies Inc (SINT)
    SINTX Technologies Inc (SINT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Vstecs Holdings Ltd:企業の戦略・SWOT・財務分析
    Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Vstecs Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Google LLC:企業の戦略的SWOT分析
    Google LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Petroleo Brasileiro S.A. (Petrobras):企業のM&A・事業提携・投資動向
    Petroleo Brasileiro S.A. (Petrobras) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Petroleo Brasileiro S.A. (Petrobras) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • CACI International, Inc.:企業の戦略・SWOT・財務分析
    CACI International, Inc. - Strategy, SWOT and Corporate Finance Report Summary CACI International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Tasly Pharmaceutical Group Co Ltd (600535):企業の財務・戦略的SWOT分析
    Tasly Pharmaceutical Group Co Ltd (600535) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Checkpoint Surgical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Checkpoint Surgical Inc (Checkpoint Surgical) is a medical device company that offers neuro-protective surgical devices. The company’s products include checkpoint stimulators and locators; and checkpoint head and neck systems. Its checkpoint stimulators and locators provide biphasic stimulat …
  • Galera Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Galera Therapeutics Inc (Galera Therapeutics) is a clinical stage biotechnology company that discovers and develops novel cancer treatments. The company also concentrates on the prevention of radiation-induced toxicity including mucositis and the treatment of cancer. Its GC4419 is a selectiv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆